Table 5.

Adverse events in the intervention and control groups.

Safety-evaluable patients∗	Control (n = 32), N (%)	Intervention (n = 32), N (%)
Serious adverse events	0	0
Epigastric pain	0	1 (3.12)
Abdominal pain	2 (6.24)	1 (3.12)
Constipation	2 (6.24)	0
Xerostomia	4 (12.5)	0
Dizziness	2 (6.25)	0
Total number of adverse events	10 (31.25)	2 (6.24)
Total number of subjects experiencing adverse events∗∗	6 (18.75)	2 (6.24)

∗ includes all patients who received at least one dose of study medication. ^∗∗P value = 0.12. Control: hyoscine; intervention: herbal medicine.